Tesfay et al. [73] reported that SCD1 was over-expressed in ovarian cancer, that the pharmacological blockade of SCD1 using CAY10566 induces apoptosis, and that, in addition, the inhibition of SCD1 can also enhance the sensitivity to ferroptosis inducers in ovarian cancer cell lines. This evidence concerns the gene SCD and ovarian carcinoma.